Literature DB >> 12194992

Cell kinetics and cell cycle regulation in lymphomas.

L Leoncini1, S Lazzi, C Bellan, P Tosi.   

Abstract

The proliferative indices of non-Hodgkin's lymphomas are useful prognostic indicators and provide information independent of other histological and clinical variables. However, proliferative indices alone do not suffice to characterise cell growth. A high cell production rate may be compensated, almost or fully, by a high cell deletion rate. A re-evaluation of parameters of cell kinetics in view of our increasing knowledge of the molecular pathways of cell cycle control may provide more prognostic information for the management of patients with malignant lymphomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12194992      PMCID: PMC1769756          DOI: 10.1136/jcp.55.9.648

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  105 in total

1.  Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells.

Authors:  C M Mueller; D W Scott
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

2.  Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features.

Authors:  M B Møller; O Nielsen; N T Pedersen
Journal:  Am J Clin Pathol       Date:  2001-03       Impact factor: 2.493

3.  Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.

Authors:  M Hinz; P Löser; S Mathas; D Krappmann; B Dörken; C Scheidereit
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

Review 4.  Regulation of the G2/M transition by p53.

Authors:  W R Taylor; G R Stark
Journal:  Oncogene       Date:  2001-04-05       Impact factor: 9.867

5.  Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.

Authors:  A Hennino; M Berard; M Casamayor-Pallejà; P H Krammer; T Defrance
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

Review 6.  Apoptosis and cancer: strategies for integrating programmed cell death.

Authors:  C J Reed
Journal:  Semin Hematol       Date:  2000-10       Impact factor: 3.851

Review 7.  B-cell receptor and Fas-mediated signals for life and death.

Authors:  G B Carey; D Donjerković; C M Mueller; S Liu; J A Hinshaw; L Tonnetti; W Davidson; D W Scott
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

8.  Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

Authors:  C Adida; C Haioun; P Gaulard; E Lepage; P Morel; J Briere; H Dombret; F Reyes; J Diebold; C Gisselbrecht; G Salles; D C Altieri; T J Molina
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

9.  The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.

Authors:  B D'Souza; M Rowe; D Walls
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

10.  Cell cycle regulators p27 and pRb in lymphomas - correlation with histology and proliferative activity.

Authors:  M Kiviniemi; I Sauroja; A Rajamäki; K Punnonen; K O Söderström; E Salminen
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

View more
  3 in total

Review 1.  Long noncoding RNAs (lncRNAs) in human lymphomas.

Authors:  Ali Gholami; Khosro Farhadi; Fatemeh Sayyadipour; Masoud Soleimani; Fakhredin Saba
Journal:  Genes Dis       Date:  2021-02-12

2.  Identifying subset of genes that have influential impacts on cancer progression: a new approach to analyze cancer microarray data.

Authors:  Mingyu Shi; Shuangge Ma
Journal:  Funct Integr Genomics       Date:  2008-05-20       Impact factor: 3.410

3.  Bombyx mori Nucleopolyhedrovirus (BmNPV) Induces G2/M Arrest to Promote Viral Multiplication by Depleting BmCDK1.

Authors:  Qin Xiao; Zhan-Qi Dong; Yan Zhu; Qian Zhang; Xiu Yang; Miao Xiao; Peng Chen; Cheng Lu; Min-Hui Pan
Journal:  Insects       Date:  2021-12-08       Impact factor: 2.769

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.